Articles | Obesity, Diabetes | 2455-8583Ceyda Tuba Sengel Turk
Current Research in Diabetes & Obesity Journal is an international peer reviewed Open Access journal of Juniper Publishers. CRDOJ is committed to increase knowledge, encouraging research and promoting better treatment for people suffering with Diabetes a
Diurnal timing of physical activity in relation to obesity and diabetes in the German National Cohort (NAKO) Michael J. Stein Andrea Weber Michael F. Leitzmann ArticleOpen Access24 Jan 2025 Are associations of adulthood overweight and obesity with all-cause mortality, cardiovascular disease, and obe...
Diurnal timing of physical activity in relation to obesity and diabetes in the German National Cohort (NAKO) Michael J. Stein Andrea Weber Michael F. Leitzmann ArticleOpen Access24 Jan 2025 Are associations of adulthood overweight and obesity with all-cause mortality, cardiovascular disease, and obe...
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Diabetes, Obesity and Metabolism are rapidly evolving fields, and healthcare professionals understandably struggle to keep-up with latest advancements.DOM NOWhelps to solve this by using our subject expert, Dr. Iskandar Idris, Associate Professor in Diabetes and Vascular Medicine at the University of ...
Obesity leads to a higher risk of death, heart disease, high blood pressure, diabetes, high cholesterol, gallbladder disease, metabolic dysfunction–associated steatotic liver disease, stroke, sleep apnea, osteoarthritis, depression, anxiety, and certain cancers (such as breast and colorectal cancers)...
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme Read now Our Publications DOM NOWcomplements the prestigious journalDiabetes, Obesity and Metabolism(DOM), by curating newsworthy and highly-valued enhanced content for busy...
GLP-1 medications like Ozempic, Wegovy, and Saxenda have gained significant popularity for treating obesity and diabetes due to their proven efficacy. However, concerns have emerged regarding potential side effects, including suicidal thoughts. In 2020, there were over 4 million prescriptions for Liragl...
This population epidemiology study uses Canadian national health care and census data to estimate changes in overweight/obesity and diabetes prevalence by